• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500316E
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/16/2020
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A user facility clinic manager (cm) reported that an internal dialyzer blood leak occurred one hour and fifteen minutes into a patient¿s hemodialysis (hd) treatment.The blood leak was reported to be visually observed.A blood test strip was used and tested positive for the presence of blood.It was confirmed that the machine, a fresenius 2008k2, alarmed appropriately with a blood leak alert.No damage was identified on the dialyzer.Fresenius bloodlines were also being utilized for the treatment.After the machine alarmed, the treatment was halted.The patient¿s blood was not returned; estimated blood loss (ebl) was 200 ml.The cm confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient completed their treatment after being re-setup with new supplies on the same machine.The dialyzer was reported to be available for a manufacturer evaluation.
 
Manufacturer Narrative
Plant investigation: the complaint device was returned to the manufacturer for physical evaluation.The corporate provided blood port caps and adapter caps were returned attached to the dialyzer.There was blood noted throughout the dialyzer and in both head caps.There was no damage noted on the returned sample.A laboratory bubble point leak test was performed on the returned sample.There were no leaks detected, possibly due to the presence of coagulated blood.The dialyzer was then subjected to destructive disassembly for further visual examination.A fiber fragment was identified at approximately 280° on the cavity id end, with the dialysate ports positioned at 0°.The fiber fragment extended from the potting surface measuring approximately 0.15 mm in length under magnification (x20).The opposing end of the fiber fragment was not located.Further examination of the complaint device did not identify any other damage or irregularities.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was then conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.The investigation into the complaint was able to confirm the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 160NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
MDR Report Key11072233
MDR Text Key223711172
Report Number1713747-2020-00530
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100149
UDI-Public00840861100149
Combination Product (y/n)N
PMA/PMN Number
K002761
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 01/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Model Number0500316E
Device Catalogue Number0500316E
Device Lot Number20KU06010
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/11/2021
Device AgeMO
Initial Date Manufacturer Received 12/17/2020
Initial Date FDA Received12/24/2020
Supplement Dates Manufacturer Received01/11/2021
Supplement Dates FDA Received01/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
FRESENIUS 2008K2 MACHINE; FRESENIUS BLOODLINES
Patient Age77 YR
Patient Weight76
-
-